For research use only. Not for therapeutic Use.
LED209(Cat No.:I002829) is a powerful small molecule inhibitor specifically designed to target the bacterial receptor QseC. It acts as a potent prodrug that exhibits high selectivity for QseC. By inhibiting QseC, LED209 disrupts the signaling pathways involved in bacterial virulence and pathogenesis. This inhibition can potentially lead to the attenuation of bacterial infections and the development of novel antibacterial strategies.
Catalog Number | I002829 |
CAS Number | 245342-14-7 |
Synonyms | (Z)-N/’-phenyl-N-(4-(N-phenylsulfamoyl)phenyl)carbamimidothioic acid |
Molecular Formula | C19H17N3O2S2 |
Purity | ≥95% |
Target | Bacterial |
Solubility | DMSO: < 3.8 mg/mL |
Storage | 2-8°C |
IUPAC Name | 1-phenyl-3-[4-(phenylsulfamoyl)phenyl]thiourea |
InChI | InChI=1S/C19H17N3O2S2/c23-26(24,22-17-9-5-2-6-10-17)18-13-11-16(12-14-18)21-19(25)20-15-7-3-1-4-8-15/h1-14,22H,(H2,20,21,25) |
InChIKey | HNDRSTUKPCLQLT-UHFFFAOYSA-N |
SMILES | C1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=C3 |
Reference | <p style=/line-height:25px/> <br>[2]. Harrison CF, et al. Adrenergic antagonists restrict replication of Legionella. Microbiology. 2015 Jul;161(7):1392-406. <br>[3]. Rasko DA, et al. Targeting QseC signaling and virulence for antibiotic development. Science. 2008 Aug 22;321(5892):1078-80. </p> |